![](/img/cover-not-exists.png)
1473PPHASE 1B TRIAL OF ANTI-NOTCH 2/3 ANTIBODY OMP-59R5 IN COMBINATION WITH ETOPOSIDE AND CISPLATIN (EP) IN PATIENTS (PTS) WITH UNTREATED EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ED-SCLC): THE PINNACLE STUDY
Pietanza, M.C., Spira, A., Jotte, R., Gadgeel, S., Mita, A., Liu, S., Gluck, W.L., Kalemkerian, G.P., Chiang, A., Hart, L., Kapoun, A., Xu, L., Hill, D., Zhou, L., Dupont, J., Spigel, D.R.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu355.11
Date:
September, 2014
File:
PDF, 66 KB
2014